等待开盘 11-19 09:30:00 美东时间
+0.020
+0.28%
ROCKVILLE, Md., Nov. 3, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the Stifel 2026 Healthcare Conference. Fireside Chat Details Date and Time:...
11-03 20:05
摩根士丹利在近日发布的研报中首次覆盖八家生物科技公司,业务涉及罕见病、眼科、肺部疾病以及神经精神疾病领域。
10-20 09:40
今日重点评级关注:Needham:维持iRhythm Holdings"买入"评级,目标价从192美元升至194美元;HC Wainwright & Co.:维持5E Advanced Materials"买入"评级,目标价从3.5美元升至6.75美元
10-06 16:45
Mizuho analyst Graig Suvannavejh initiates coverage on Regenxbio (NASDAQ:RGNX) with a Outperform rating and announces Price Target of $22.
10-05 17:47
Regenxbio (RGNX) is up ~3% in Friday morning trading after recently appointed director Gregory Austin Ciongoli bought more than 102,000 shares valued at more than $949,000. An SEC filing shows that he...
08-28 21:57
今日重点评级关注:摩根大通:维持Ultragenyx Pharmaceutical"超配"评级,目标价从75美元升至80美元;瑞杰金融:维持英伟达"强力买入"评级,目标价从330美元升至352美元
08-26 08:37
ROCKVILLE, Md., Aug. 25, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced the appointment of Greg Ciongoli to its Board of Directors, effective August 25, 2026. With multip...
08-25 19:05
Baird analyst Brian Skorney maintains Regenxbio (NASDAQ:RGNX) with a Outperform and lowers the price target from $32 to $29.
08-25 18:29
ROCKVILLE, Md., Aug. 24, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today provided an update on its investigational gene therapy, RGX-121 (clemidsogene lanparvovec), for the treatmen...
08-24 19:05
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45